TY - JOUR
T1 - A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities
T2 - Preliminary observations
AU - Gherlinzoni, F.
AU - Bacci, G.
AU - Picci, P.
AU - Capanna, R.
AU - Calderoni, P.
AU - Lorenzi, E. G.
AU - Bernini, M.
AU - Emiliani, E.
AU - Barbieri, E.
AU - Normand, A.
PY - 1986
Y1 - 1986
N2 - A new trial for evaluating the effectiveness of adjuvant chemotherapy in high-grade soft-tissue sarcomas of the extremities in adult patients is presented. All patients after local treatment were randomized into two arms, one without further therapy and the other to receive adjuvant chemotherapy (Adriamycin [Farmitalia-Carlo Erba, Milan, Italy], 450 mg/m2). The preliminary results of the study are reported at a median observation period of 27.6 months. Of the 59 patients who entered the study, 79.1% in the chemotherapy group are without sign of disease, whereas the corresponding figure in the nonadjuvant chemotherapy group is 54.3%. The difference between the two groups is statistically significant (P <.005, log rank test). These preliminary observations encourage continuation of the study.
AB - A new trial for evaluating the effectiveness of adjuvant chemotherapy in high-grade soft-tissue sarcomas of the extremities in adult patients is presented. All patients after local treatment were randomized into two arms, one without further therapy and the other to receive adjuvant chemotherapy (Adriamycin [Farmitalia-Carlo Erba, Milan, Italy], 450 mg/m2). The preliminary results of the study are reported at a median observation period of 27.6 months. Of the 59 patients who entered the study, 79.1% in the chemotherapy group are without sign of disease, whereas the corresponding figure in the nonadjuvant chemotherapy group is 54.3%. The difference between the two groups is statistically significant (P <.005, log rank test). These preliminary observations encourage continuation of the study.
UR - http://www.scopus.com/inward/record.url?scp=0022620002&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022620002&partnerID=8YFLogxK
M3 - Article
C2 - 3514804
AN - SCOPUS:0022620002
VL - 4
SP - 552
EP - 558
JO - Journal of Clinical Oncology
JF - Journal of Clinical Oncology
SN - 0732-183X
IS - 4
ER -